Objectives: Sickle cell disease (SCD) is a serious illness with disabling acute and chronic pain that needs better therapies, but insufficient patient participation in research is a major impediment to advancing SCD pain management. The purpose of this article is to discuss the challenges of conducting an SCD study and approaches to successfully overcoming those challenges. Design: In a repeated-measures, longitudinal study designed to characterize SCD pain phenotypes, we recruited 311 adults of African ancestry. Adults with SCD completed 4 study visits 6 months apart, and age-and gender-matched healthy controls completed 1 visit. Results: We recruited and completed measures on 186 patients with SCD and 125 healthy controls. We retained 151 patients with SCD with data at 4 time points over 18 months and 125 healthy controls (1 time point) but encountered many challenges in recruitment and study visit completion. Enrollment delays often arose from patients' difficulty in taking time from their complicated lives and frequent pain episodes. Once scheduled, participants with SCD cancelled 49% of visits often because of pain; controls canceled 30% of their scheduled visits. To facilitate recruitment and retention, we implemented a number of strategies that were invaluable in our success. Conclusion: Patients' struggles with illness, chronic pain, and their life situations resulted in many challenges to recruitment and completion of study visits. Important to overcoming challenges was gaining the trust of patients with SCD and a participant-centered approach. Early identification of potential problems allowed strategies to be instituted proactively, leading to success.
Introduction
Pain research with the 100 000 Americans with sickle cell disease (SCD) is critically important to meet the urgent need for new treatments that alter the disabling effects of the disease's most common symptom-acute and chronic pain. 1, 2 Sickle cell disease, a genetic condition that in the United States affects people of mainly African or Latin descent, 3 is known for death at early age. Median age at death for women was 42 years and for men was 38 years. 4 Only 3 treatments, hydroxyurea, stem cell transplant, and L-glutamine, have favorably impacted the disease course of patients with SCD but are not widely used. [5] [6] [7] The Improving Patient Outcomes with Respect and Trust (IMPORT) study of attitudes of 291 patients with SCD on seeking health care revealed that up to 92% of participants felt positive about participating in clinical trials. 8 There is an incongruity, however, between IMPORT findings of high level of support for research studies by patients with SCD and the realities of low enrollment and retention of patients with SCD in research studies. 9 Insufficient patient participation in clinical trials is a major impediment to the advancement of SCD research. 9 Many SCD studies are terminated due to low enrollment. 9, 10 Therefore, conducting a longitudinal study can be challenging with a population that has a debilitating chronic disease, many of whom live in inner-city neighborhoods and may have complicated life situations. 11, 12 The purpose of this article is to discuss the challenges and successes of conducting such a study in a major metropolitan city.
The goal of our study was to characterize SCD pain to improve pain control in adults with SCD. We describe our challenges in conducting the study, strategies, and initiatives that led to its successful completion and budget implications of the personnel time required to achieve success. Although many patients were interested in joining the study, the realities of their struggles with illness, chronic pain, and their life situations resulted in many challenges to recruitment and completion of the study's 4 visits over 18 months.
Methods

Study Design
This was a repeated-measures, longitudinal study with adults of African ancestry and SCD pain to characterize the phenotypes of chronic pain and associate phenotypes with genomic characteristics. We repeated measures every 6 months, in cold and warm seasons, for a total of 4 measures over 18 months. The study also included a cross-sectional, single session of healthy controls of African ancestry with similar measures. The study was approved by the University of Illinois at Chicago (UIC) Institutional Review Board (approval number 2014-0287). All participants provided written informed consent for participation.
Setting and Sample
Participants with SCD were recruited at the University of Illinois Hospital and Health Sciences System (UIH) outpatient adult SC clinic, which has about 600 patients. Healthy controls were recruited from the community. Study procedures were conducted at the UIC College of Nursing, located 2 blocks from the clinic.
Inclusion criteria for patients were (1) SCD diagnosis, (2) moderate-to-severe pain (>3 on 0-10 scale) related to SCD within the last 12 months, (3) chronic SCD pain, defined as pain >0 on at least half of the days during the previous 3 months, (4) spoke and read English, (5) >18 years old, and (6) African ancestry. Patients were excluded if they were legally blind, physically or cognitively unable to complete study measures, or diagnosed with a polyneuropathy or diabetes. We recruited and completed baseline measures on 186 patients with SCD.
Inclusion criteria for the healthy controls were (1) African ancestry; (2) health history negative for diabetes, hypertension, SCD, sickle cell trait (SCT), cancer, current acute, or chronic pain; (3) spoke and read English; and (4) >18 years old. Controls were excluded if they were legally blind, physically or cognitively unable to complete study measures, or reported using prescription pain medications or recreational drugs. We recruited and completed the single-session measures on 125 healthy controls.
Procedures
After recruitment at the UIH SC clinic or the community, potential participants with SCD were scheduled for consent and baseline data collection. After informed consent, the researcher obtained blood for genetic and epigenetic analyses. The consent process stressed that participating in the study was voluntary and that samples would only be identified with a code number, and participants' identifiable data would be shared only with the investigators. Then, participants completed Internet-based self-report tools for pain, symptoms, health-related quality of life, and impact of pain on their lives and completed thermal and mechanical quantitative sensory testing (QST). We conducted thermal QST using a Medoc Advanced Medical Systems TSA-II analyzer (Ramat Yishai, Israel) to quantify their responses to cool, warm, cold, and hot stimuli and mechanical QST using von Frey filaments to study their response to pressure. 13, 14 For patients, blood samples and measures were obtained 3 more times at alternate seasons with the goal of obtaining 2 measures in warm/hot season and 2 in cool/cold season. Each visit lasted 1.5 to 3 hours. Participants received US$50/visit.
Results
The Research Team
Over the past 15 years, the study investigators and team members have successfully completed 13 trials in patients with SCD. This study team consisted of the same project director and 3 research specialists (RSs) who have been part of the team between 8 and 15 years. The RSs were responsible for recruitment, retention, and data collection. They had extensive experience recruiting for SCD research studies. Having interacted with the SC clinic physicians, staff, and patients over the years in previous studies, the RSs were familiar with many patients and had gained their trust. 12, 15 This bond facilitated approaching and recruiting them. Additionally, patients who knew the RSs often vouched for our team and encouraged other patients to join this study. This peer endorsement was invaluable in our efforts to involve new patients in our research. Having the same highly trained and efficient team with a proven record of success in SCD studies was instrumental to the success of this study.
Patients with SCD were recruited mainly in person at the SC clinic. We used Facebook to contact participants from earlier studies from whom we had permission and contact current participants for follow-up visits. Attempts to recruit patients through Craigslist were unsuccessful. We participated in outreach activities with the Sickle Cell Disease Association of Illinois and Have a Heart for Sickle Cell Anemia Foundation (HHSCA) to build relationships with the SC community. Outreach activities included participating in Advocacy Day for SC events to lobby Illinois legislators for laws supporting SCD and joining the executive board of HHSCA. Despite all these recruitment activities, 95% of participants with SCD were recruited at the SC clinic.
Recruitment was aided by attractive flyers with our unique SCD brand, 15 designed by the team's graphic designer ( Figure 1 ). Also, an RS visited the clinic during regular hours to introduce the study to potential participants. However, patients often had to leave right after their appointments, and we often approached patients multiple times in person or by phone, since they frequently expressed interest in being contacted later. It was very time-consuming and labor-intensive to approach the same patients numerous times before enrollment.
The RSs divided their time between recruitment, screening, scheduling, and data collection, and we attempted to have the same RS work with the same participant at all visits. This approach was very successful for retention, since participants were more likely to respond and return for follow-up visits when contacted by a more familiar RS. However, as the study progressed, the RSs spent more time on scheduling visits and completing data collection and less time on recruitment.
Additionally, as the patients who were more interested in participation had joined, it became more difficult to recruit new participants from the large but limited clinic pool. In the first 4 months of the study, our SCD recruitment rate was 11.8 participants/month. Over the next 12 months, recruitment decreased to 6.2 participants/month and in the next 9 months to 3.7 participants/month. As the study progressed, and there were fewer patients available for recruitment and the RSs were less able to focus on recruitment, we temporarily assigned another RS to recruit full time at the clinic during the last few months. With this focused effort, recruitment increased 2.5 times, averaging 9.3 participants/month.
We recruited healthy controls from the community, through Craigslist, referrals from patients with SCD and word of mouth. Recruitment of healthy controls was easier due to a much larger pool of potential participants who did not have the crippling effects of SCD.
Scheduling, Cancellations, Rescheduling, and Missed Visits
One of our biggest challenges was scheduling and completing study visits. Visits were usually scheduled by phone or text messages, and most took multiple attempts to be scheduled. Once scheduled, we had an inordinate number of cancelations; 49% of the SCD visits were canceled. By contrast, 30% of those with healthy controls were canceled. The primary reason for cancellation by participants with SCD was that they were in pain or in pain crisis, in the emergency department, or admitted to the hospital. Other reasons for missed visits included lack of transportation or childcare, work issues, and bad weather, which could lead to pain crises. Some could not be reached or did not return calls before the scheduled visit, despite many contact attempts. Most participants rescheduled their visits, although rescheduling also presented challenges since we had to contact them additional times. The main reasons for cancelation by the healthy controls were because of work or family complications or losing interest in participation.
To facilitate attendance, the RSs scheduled visits on evenings and weekends, as needed. When participants were dealing with illness, as well as work, school, family, childcare, and other life issues, the RSs flexibility facilitated their continued participation. Equally important, when they canceled visits, often multiple times, the RSs were understanding, at no time pressuring participants. To minimize cancellations, we entertained children when parents lacked childcare, secured wheelchairs for people with mobility challenges, and picked up participants at the clinic or other UIC location, among other initiatives.
Other Strategies for Success
Continuous monitoring of recruitment and data collection progress was essential in this process. Recruitment and retention progress was a standing agenda item for the weekly team meetings. This monitoring allowed us to modify our processes and replan as necessary to ensure proper progress of the study. Other strategies that aided success included the RSs receiving additional training, as needed. For example, the study involved blood draws for genetic analyses, but going to the phlebotomy laboratory was complicated and time-consuming. The RSs received phlebotomy training to remove this barrier. To dispel patients' concerns about the length of the study or the possibility of the procedures causing pain, we prepared a short video where a participant well known to most clinic patients talked about her participation. Another initiative was providing parking close to the study site. In a big city and with a participant population living with a chronic condition, convenient parking facilitated participation and was genuinely appreciated. Finally, participants received US$50 for every completed study visit in compensation for their time and expenses.
As in any longitudinal study, we were concerned about retention. To facilitate retention, we obtained the participant's phone number and other contact methods such as e-mail address, alternate phone, and Facebook. We gave them a certificate of completion at study end (Figure 2 ). They were pleased to receive this token of our appreciation for their contribution to the scientific understanding of SCD pain.
Recruitment and Retention Outcomes of Strategies
A total of 354 patients with SCD and 233 healthy controls were screened, and 325 patients with SCD and 201 controls were eligible. Patients with SCD who were eligible but did not join the study (n ¼ 139) were either not interested (n ¼ 43) or expressed interest but never scheduled the first visit (n ¼ 96). Major ineligibility reasons among the patients with SCD were low pain scores (n ¼ 15) and diabetes (n ¼ 9) and for the healthy controls were SCT (n ¼ 8), hypertension or diabetes (n ¼ 8), or pain (n ¼ 7). We successfully recruited and completed baseline measures on 186 patients with SCD and 125 healthy controls, surpassing our targets of 180 and 115, respectively. We were also successful in recruiting patients who had not joined our previous SCD studies. Of 186 participants, 110 (59%) were new. It is also notable that 76 (41%) participants had joined at least 1 previous study in which SCD pain was a focus. We have collected the same pain measures over time, up to 10 years in some cases, for this group.
We also completed 498 SCD follow-up visits at approximately 6, 12, and 18 months after baseline (809 total visits). Between March 2015 and the end of the study on February 2019, we scheduled 1531 study visits, including those for the healthy controls, but conducted only 809. The 722 visits canceled included, in many cases, multiple cancellations for the same participant, although most canceled visits were rescheduled. The majority of visits were canceled at the last minute, or participants did not show up. Since the visits were 1.5 to 3 hours long, we scheduled 3-hour slots to ensure completion without interruption. Last moment cancellations meant that the instruments and resources were idle during that time, since it was extremely difficult to schedule another visit at short notice.
Despite the enormous challenges in completing study visits, our overall attrition was low. Of the 186 patients with SCD who enrolled, 151 completed all 4 data collection points, exceeding our target of 150 patients with full data, while 17 completed 3 data collection points, 11 completed 2, and 7 completed only the baseline visit. The 35 patients who missed visits included 7 participants with SCD who while in study died due to their illness. The attrition for the healthy controls was 5%. This indicated commitment to the study, in many cases because of an interest in helping others with SCD, since many were referrals from patients with SCD or knew people with this disease. Healthy controls responding to Craigslist appeared to be more interested in the US$50 stipend.
Discussion
We encountered many challenges in our recruitment, retention, and visit completion in individuals with SCD and used a number of strategies that were invaluable to our successes in this longitudinal study. Patients with SCD were in general interested in joining the study as evidenced by the fact that only 12% of approached patients expressed no interest in participation. 9 The difficulty in recruitment often arose from patients' difficulty in making time from their complicated lives to schedule the first visit, especially because they may have been in pain.
Also essential was having a well-trained and experienced team of RSs, who had gained the trust of the patients with SCD through previous interactions, who were highly perseverant in their attempts to recruit and schedule participants, and who allowed flexibility to ensure maximum convenience for participants. Constant monitoring of recruitment and data collection status enabled early identification of potential problems and allowed us to proactively institute the strategies that led to success. Once the patients with SCD entered the study, they tended to remain probably assisted by the commitment of our study personnel.
One major implication of our successful strategies is that it can be extremely costly in terms of personnel time to successfully complete a longitudinal study in a population suffering from a debilitating disease. Although we did not track the time invested in enrolling each individual and successfully scheduling each data collection point, the numerous times we had to approach many potential participants before enrollment and numerous cancellations and rescheduling of visits required an extraordinary amount of time and full attention of our 3 RSs. Success comes with a lot of effort, particularly when dealing with a population living with a chronic condition, many of whom had complicated lives. When developing a research budget, investigators need to account for additional time and labor costs necessary to reapproach patients to enroll them in a study.
A limitation was that we did not keep specific records as to why each participant missed appointments. Anecdotally, we know that many of the participants with SCD did not keep their appointments due to pain, and we recommend specifically documenting the reasons why each study session is missed in future studies. Sufficient study personnel are needed to address the unique needs of SCD study participants, including a liaison function to the SC clinic to coordinate analgesic needs.
Conclusion
The clarification of processes for successful recruitment of patients into SCD studies is important, as they have been plagued by low recruitment and retention. Our research team has discovered successful approaches and a proven track record of strong and experienced leadership and recruitment in SCD studies. Our monitoring processes and kind, professional, and consistent approach are necessary components of performing a research study with this chronic pain population.
